Award
Delivery Order #SPE2DR26FL311
Delivery Order for Novolog Vials under AmerisourceBergen Pharmaceutical Contract
Buyer
Defense Logistics Agency
Award Amount
$1,345.63
Ceiling
$1,345.63
Awarded
February 23, 2026
Period of Performance
Feb 23, 2026 – Feb 24, 2026
Identifier
SPE2DR26FL311
NAICS
424210
This is a delivery order contract awarded to AmerisourceBergen Drug Corporation, a prominent healthcare solutions provider specializing in pharmaceutical distribution. The contract involves the procurement of Novolog insulin vials, specifically 100 unit/mL concentrations packaged in 10 mL vials, essential for managing diabetes treatment. This delivery order supports the parent indefinite delivery/indefinite quantity (IDIQ) contract that facilitates the ongoing supply of critical pharmaceutical products to healthcare agencies, thereby ensuring consistent patient care and medication availability. The work under this delivery order covers the timely delivery of these specific insulin vials with performance expected within a short, defined timeframe. Awarded through the existing IDIQ vehicle, the contract benefits from prior competitive acquisition. The award was recently issued with a concise performance period, underscoring its focused and immediate fulfillment within the broader multi-year pharmaceutical supply program.
Description
4570924392!NOVOLOG 100 UNIT/ML VIAL 10ML